Tyler Paz Korman

CIK: 0002032745

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (40.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EXOZ

EXOZYMES INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

EXOZ
EXOZYMES INC.
Aug 19, 2026
Exercise(M)
Direct
33K shares-
EXOZ
EXOZYMES INC.
Apr 9, 2026
Sale(S)
Direct
750 shares at avg. $10.53$8K
EXOZ
EXOZYMES INC.
Apr 8, 2026
Sale(S)
Direct
750 shares at avg. $10.04$8K
EXOZ
EXOZYMES INC.
Apr 1, 2026
Award(A)
Direct
5.3K shares at avg. $8.44$45K
EXOZ
EXOZYMES INC.
Jun 16, 2025
Award(A)
Direct
3K shares at avg. $12.54$37K

		Type	Shares	Price		Ownership
Aug 19, 2026	EXOZ EXOZYMES INC.	Exercise(M)	32,964	-	$0	Direct
Apr 9, 2026	EXOZ EXOZYMES INC.	Sale(S)	750	$10.53	$7,894	Direct
Apr 8, 2026	EXOZ EXOZYMES INC.	Sale(S)	750	$10.04	$7,530	Direct
Apr 1, 2026	EXOZ EXOZYMES INC.	Award(A)	5,332	$8.44	$45,002	Direct
Jun 16, 2025	EXOZ EXOZYMES INC.	Award(A)	2,990	$12.54	$37,495	Direct

1-5 of 5 transactions

About Korman Tyler Paz

Korman Tyler Paz (SEC CIK 0002032745) files insider reports with the SEC as Chief Scientific Officer of EXOZYMES INC. (EXOZ).

Signal8 holds 6 ownership filings by Korman Tyler Paz (1 Form 3, 5 Form 4), filed between Nov 18, 2024 and Oct 21, 2026. Those filings report 5 transactions, from Jun 16, 2025 to Aug 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Korman Tyler Paz's filings is in MONROVIA, CA.

Recent filings by Korman Tyler Paz

Aug 19, 2026: Option exercise of EXOZ shares (Form 4, code M).
Apr 9, 2026: Open-market sale of EXOZ shares (Form 4, code S).
Apr 8, 2026: Open-market sale of EXOZ shares (Form 4, code S).
Apr 1, 2026: Grant or award of EXOZ shares (Form 4, code A).
Jun 16, 2025: Grant or award of EXOZ shares (Form 4, code A).

Other insiders filing for EXOZYMES INC. (EXOZ)

Perriman Damien Alan, Chief Commercial Officer
Rayo Edgardo Javier, Director
MARLETT CHRISTOPHER A, Director
Lalonde James Joseph, Director
DIGIANDOMENICO ANTHONY, Director
Bowie James Ulrich, Director

How to read Form 4 transaction codes